Skip to main content
Caplight Logo









NanoDx

NanoDx

Private
Southborough, MassachusettsHealthcare & Life Scienceshttps://nanodiagnostics.com/

Last Round

Series C

Jul 1, 2020

Total Funding Raised

$25.95M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

NanoDx is a medical device company that develops point-of-care products for the objective diagnosis and management of concussions and other traumatic brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Sensors

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

point-of-care diagnosticsnanowire biosensorsPOC testingmedical devicein-vitro diagnosticsIVDdiagnostic analyzerbiomarker detectionrapid testingtraumatic brain injury diagnosticsTBI testingrazor-and-blade modelclinical diagnosticslab-on-a-chipbiosensor technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoDx Comparables

Compare NanoDx with similar companies based on industry and business-model similarity.

NanoDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanopath
85%
BrainScope
83%
BRAINBox Solutions
78%

NanoDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 1, 2020
VC RoundApr 10, 2017
Series BFeb 3, 2016
Series AAug 19, 2013

NanoDx Investors

Notable investors and investment history

NanoDx investors
InvestorRounds
Paulson Investment CompanySeries A
Provident Healthcare CapitalVC Round, Series B
MedScience VenturesVC Round
Shepherd Kaplan KrochukSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 42% MoM, reaching 1.3K.

  • Jan 20, 2026

    Monthly visitors increased 63% MoM.

NanoDx Filings

Explore SEC and related filing metadata, where available.

NanoDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NanoDx's valuation, stock price, and market status.

Is NanoDx a public or private company?

NanoDx is a private company.

What is the current stock price of NanoDx?

NanoDx is a private company with no public stock price. No recent secondary market data is available.

How much is NanoDx worth (valuation)?

Valuation information for NanoDx is not publicly available.

Can I buy NanoDx stock?

NanoDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NanoDx's last funding round?

NanoDx's most recent funding round was Series C on July 1, 2020.

Who are the main investors in NanoDx?

Key investors in NanoDx include Provident Healthcare Capital, Shepherd Kaplan Krochuk.

Will NanoDx IPO soon?

No public IPO plans have been announced for NanoDx.

How can I track NanoDx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NanoDx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouthborough, Massachusetts
Employee Range24
Year Founded2010
Last FundingJul 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?